A high quality, accessible cell therapy for Parkinson’s Disease produced in a scalable bioreactor system for 3D cell expansion and differentiation

  • Post author:
  • Post category:

Translational Candidate Human pluripotent stem cell expanded and differentiated dopaminergic precursor cells to treat Parkinson’s Disease at high quantity and high quality Area of Impact This candidate uses a 3D…

Continue ReadingA high quality, accessible cell therapy for Parkinson’s Disease produced in a scalable bioreactor system for 3D cell expansion and differentiation

Clinical Translation of Allogenic Regenerative Cell Therapy for White Matter Stroke and Vascular Dementia

  • Post author:
  • Post category:

Translational Candidate Human induced pluripotent stem cell-derived glial enriched progenitors Area of Impact Vascular dementia and white matter stroke, addressing a current bottleneck of poor scale up for existing cell…

Continue ReadingClinical Translation of Allogenic Regenerative Cell Therapy for White Matter Stroke and Vascular Dementia

Clinical Translation of Allogenic Regenerative Cell Therapy for White Matter Stroke and Vascular Dementia

  • Post author:
  • Post category:

Translational Candidate Human induced pluripotent stem cell-derived glial enriched progenitors Area of Impact Vascular dementia and white matter stroke, addressing a current bottleneck of poor scale up for existing cell…

Continue ReadingClinical Translation of Allogenic Regenerative Cell Therapy for White Matter Stroke and Vascular Dementia

Development of a human stem cell-derived inhibitory neuron therapeutic for the treatment of chronic focal epilepsy

  • Post author:
  • Post category:

Translational Candidate A cellular therapeutic comprised of inhibitory nerve cells produced from human stem cells Area of Impact Drug-resistant chronic temporal lobe epilepsy Mechanism of Action The product candidate is…

Continue ReadingDevelopment of a human stem cell-derived inhibitory neuron therapeutic for the treatment of chronic focal epilepsy

Human Neural Stem Cells (hNSCs) for neuroprotection in perinatal hypoxic-ischemic brain injury (HII)-Pre-IND-enabling Studies

  • Post author:
  • Post category:

Translational Candidate An established stable human neural stem cell line unmanipulated genetically & propagated under defined conditions Area of Impact Perinatal asphyxia (also called hypoxic-ischemic injury), a major untreatable cause…

Continue ReadingHuman Neural Stem Cells (hNSCs) for neuroprotection in perinatal hypoxic-ischemic brain injury (HII)-Pre-IND-enabling Studies

NeuBright, a purified allogeneic cell therapy product for treatment of Dry Age-related Macular Degeneration

  • Post author:
  • Post category:

Translational Candidate NeuBright is an allogeneic cryopreserved neural stem cell therapy product Area of Impact Dry Age-Related Macular Degeneration (AMD) Mechanism of Action Similar to RPE cells, NeuBright cells restore…

Continue ReadingNeuBright, a purified allogeneic cell therapy product for treatment of Dry Age-related Macular Degeneration